Certolizumab pegol efficacy is greater with more recent-onset Crohnʼs Disease

Authors :: J McColm
J.-F. Colombel
W J Sandborn
Stefan Schreiber
Julián Panés
Jürgen Schölmerich
Source :: Inflammatory Bowel Diseases. 13:672
Publication Year :: 2007
Publisher :: Oxford University Press (OUP), 2007.

Subjects :: medicine.medical_specialty
business.industry
Internal medicine
Gastroenterology
medicine
Immunology and Allergy
Disease
Certolizumab pegol
Recent onset
business
medicine.drug

Tools